Fena Open Banking — fast, secure, no card fees Minimum order £15 Per-batch COA on every product
Light Peptides

Peptide Research Overviews: Compound-by-Compound Evidence

Compound research hub
The Research hub reviews individual peptides one compound at a time — what has actually been studied, how strong the human evidence is, and where the important gaps remain. Each overview is neutral, evidence-status labelled and contains no dosing or personal-use guidance.

Reviewed by the Light Peptides Editorial Team · Last updated 17 July 2026

Key points

  • Each overview separates preclinical signals from proven human outcomes.
  • Evidence-status labels show whether a compound is mainly preclinical, has limited human data, or is authorised.
  • Overviews link to the relevant product, its batch documentation and related comparisons.

Compounds covered so far

Each overview follows the same structure: what the compound is, what has been studied, how much human evidence exists, and the limitations that remain.

  • BPC-157 — a synthetic pentadecapeptide studied mainly in animal models.
  • TB-500 & thymosin beta-4 — terminology, related sequences and evidence gaps.
  • MOTS-c — a mitochondrial-derived peptide studied in metabolic research.
  • GHK-Cu — a copper-binding tripeptide studied in skin and tissue research.
  • Multi-peptide research blends — how blends complicate evidence and testing.

Explore the research catalogue

Browse Light Peptides research materials — each supplied with batch-specific documentation.

Browse the research catalogue

For laboratory research only. Not for human consumption.